Seeing Is Believing
Healthcare - Sector
KALA is currently covered by 2 analysts
Kala Pharmaceuticals's activity chart (see below) currently has 29 price targets and 28 ratings on display. The stock rating distribution of KALA is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 26.53% with an average time for these price targets to be met of 93.83 days.
Highest price target for KALA is $17, Lowest price target is $17.
Most recent stock forecast was given by from HC WAINWRIGHT on 17-Sep-2025. First documented stock forecast 13-Aug-2017.
Currently out of the existing stock ratings of KALA, 2 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 06-Mar-2023
$35
$32.48 (1288.89%)
$12
1 years 20 days ago
(17-Sep-2025)
7/15 (46.67%)
$17.53 (100.34%)
232
Buy Since 11-Sep-2025
$33
$30.48 (1209.52%)
1 years 26 days ago
(11-Sep-2025)
0/1 (0%)
$16 (94.12%)
Buy Since 01-Jun-2020
$15
$12.48 (495.24%)
$15
1 years 5 months 23 days ago
(14-Apr-2025)
5/6 (83.33%)
$11.51 (329.80%)
307
Buy
4 years 1 months 22 days ago
(14-Aug-2022)
0/2 (0%)
$390 (108.33%)
Sell
$75
$73.69 (5625.19%)
4 years 6 months 7 days ago
(29-Mar-2022)
0/2 (0%)
$2 (2.74%)
What is KALA (Kala Pharmaceuticals) average time for price targets to be met?
Which analyst most recently updated their price target on KALA (Kala Pharmaceuticals)?
Which analyst has the most public recommendations on KALA (Kala Pharmaceuticals)?
Which analyst is the currently most bullish on KALA (Kala Pharmaceuticals)?
Which analyst is the currently most reserved on KALA (Kala Pharmaceuticals)?